{"text": ["Pfizer", "(PFE)", "Gains", "As", "Market", "Dips:", "What", "You", "Should", "Know"], "created_at": "2019-10-14 21:45:09"}
{"text": ["Johnson", "and", "Johnson", "Stock", "Still", "Significantly", "Undervalued"], "created_at": "2019-10-14 19:59:43"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Novartis,", "J&J,", "Pfizer,", "Novo", "Nordisk", "and", "Glaxo"], "created_at": "2019-10-14 14:15:02"}
{"text": ["Lilly", "Gets", "FDA", "Approval", "for", "New", "Oral", "Tablets", "for", "Migraine"], "created_at": "2019-10-14 14:14:02"}
{"text": ["Why", "cell", "therapies", "are", "cancer's", "next", "frontier"], "created_at": "2019-10-14 13:14:28"}
{"text": ["Market", "Morning:", "Economists", "Say", "Spend", "More,", "Viagra", "For", "Leukemia,", "Aerospace", "Mergers"], "created_at": "2019-10-14 11:00:25"}
{"text": ["ImaginAb", "signs", "multi-party", "collaboration", "agreement", "with", "three", "global", "pharmaceutical", "companies", "to", "help", "further", "develop", "company's", "CD8", "ImmunoPET", "technology"], "created_at": "2019-10-14 06:00:00"}
